Embed Size (px)
Citation preview
StreetRx Price Comparison
Non-Bulk
vsBulk
StreetRx.com
THE RADARS® SYSTEMStreetRx has been part of the RADARS System since 2010. The Researched Abuse, Diversion and Addiction-Related Surveillance collects timely product- and geographically-specific data on rates of abuse, misuse, and diversion, contributing to the understanding of trends and aiding the development of effective interventions.
StreetRx (streetrx.com) is a collection of databases, websites, and citizen reports enabling real-time collection, organization, and display of street price data on diverted pharmaceutical controlled substances. Based on principles of crowdsourcing for public health surveillance, the site allows users to anonymously submit prices they paid or heard were paid for diverted prescription drugs.
Unique Visitors per Day
130
250
16412616
MobileAccounts for 80%
of visits
Search86% of visits come from
organic search
Average daily visitors per year identified by Google Analytics
2012
2015
As of April 27, 2015. Not to scale.
Visitor DemographicsBased on 58% of known demographics from Google account users
20%Male
35+ years-old
43%Male
18-34 years-old
15%Female35+ years-old
22%Female
18-34 years-old
As captured by Google Analytics. January 1 through March 31, 2015
42,058 Referrals to Health OrganizationsFrom November 1, 2010 through March 31, 2015
Drug Treatment & Harm
ReductionSubstance abuse treatment locators, overdose prevention
Chronic PainAdvocacy and support organizations
Proper Disposal and
StorageDEA and non-profit
organizations
1,750 1,4381,318
1,420
4,565
1,356
1,4322,062
Percent Discount for ADF VersionsPutative abuse-deterrent formulation versus unprotected formulations with same active ingredient, using statistical comparison that is less influenced by outliers.
4% 36%
45%
54%
7% 22%
25%
42%
55%
Physical Barrier Prodrug(Partial-)Antagonist
Conc
erta
Exal
go
Opa
na E
R
Oxy
Conti
n O
P
Zohy
dro
Vyva
nse
code
ine
Subo
xone
tabl
et
Xart
emis
XR
p<.01
z -38
p<.01
z -38
p<.01
z -3.0
p<.01
z -3.7
p=.78
z 0.3
p<.01
z -8.6
p<.01
z -13
p=.34
z -0.9
p=.24
z -1.2
TBD
?
OROSOROSINTAC INTAC PolyOx
29%
Rita
lin L
A
p<.01
z -3.9
SODAS
24%
Nuc
ynta
ER
p=.10
z -1.6
INTAC
29%
Hys
ingl
a ER
p=0.46
z -0.7
INTAC INTAC
Which drugs have greatest volume discounts?On the black market
STEP 1
STEP 3
STEP 2
STEP 4
USA Data in USDNov 1, 2010 through Mar 31, 2015Solid oral formulations Compare bulk (10+ units) purchases with “retail” purchases, by active ingredient
N = 52,849Price per milligramGeometric means and 95% CINon-parametric Wilcoxan rank-sum (Mann-Whitney) tests
BenzodiazepinesMuscle Relaxers
StimulantsErectile Dysfunction
BenzodiazepinesPercent discount for bulk purchases (10+ at a time)
diazepamn=507
z=3.7 p<0.01
34%
25%
22%
10%
clonazepamn=3,161
z=6.1 p<0.01
alprazolamn=4,583
z=8.7 p<0.01
lorazepamn=1,271
z=1.8 p=0.07
Muscle Relaxers & Neuropathic Pain RelieversPercent discount for bulk purchases (10+ at a time)
pregabalinn=21
z=1.3 p=0.19
48%
46%
22%
0%
gabapentinn=146
z=1.2 p=0.25
carisoprodoln=239
z=3.6 p<0.01
tizanidinen=47
ns
Sleep AidsPercent discount for bulk purchases (10+ at a time)
eszopiclonen=9
z=0.5 p=0.60
59%
30%
24%zolpidem
n=287z=3.3 p<0.01
zaleplonn=8
z=0.5 p=0.61
Erectile DysfunctionPercent discount for bulk purchases (10+ at a time)
tadalafiln=142
z=4.0 p<0.01
73%
61%
0%vardenafil
n=15ns
sildenafiln=251
z=3.8 p<0.01
Percent Discount for Bulk Purchase
Sleep Aids Erectile
Dysfunction
Benzodiazepines Stimulants Opioid AnalgesicsMuscle Relaxants
39% 23% 14% 38% 12% 67%
OpioidsPercent discount for bulk purchases (10+ at a time)
methadonen=852
z=2.6 p<0.01
oxycodonen=9,910
z=8.6 p<0.01
hydromorpho
nen=1,664
z=2.8 p<0.01
hydrocodonen=6,062
z=7.0 p<0.01
14%
13%
12%
10%
StimulantsPercent discount for bulk purchases (10+ at a time)
modafiniln=87
z=1.5 p=0.13
32%
15%
8%
3%
methylphenid
aten=1,607
z=1.7 p=0.09
amphetamine
sn=13,828
z=9.1 p<0.01
lisdexamphetami
nen=2,038
z=1.8 p=0.07
Descriptive Results Abuse/tamper deterrent formulationOriginal unprotected formulation
95% Confidence interval of the geometric mean
